【24h】

New Activated Carbon Drugs

机译:新的活性炭药物

获取原文
获取原文并翻译 | 示例

摘要

New water-soluble cellulose derivative (WSCD) of polyelectrolyte nature has been suggested for preparing quicklyrndisintegrated drug forms of activated carbon and also combined drugs containing both aspirin, antacid, antibiotics etc. andrncarbon. The results of sedimentation analysis, studies of aggregative stability and rheological properties of suspensions ofrnfibrous activated carbon in the presence of new and well-known water-soluble polymers have been reviewed. It has beenrnfound that suspensions stabilized by WSCD display the lowest degree of structuring, the highest stability, narrower particlernsize distribution, and greater amount of particles incapable of gravity sedimentation. Such physicochemical suspensionrncharacteristics in combination with high specific surface and sorption activity allow obtaining drugs with increasedrnbioavailability, reducing the therapeutic dose and treatment period.
机译:已经提出了具有聚电解质性质的新型水溶性纤维素衍生物(WSCD),用于制备活性碳的快速崩解药物形式,以及包含阿斯匹林,抗酸剂,抗生素等和碳的组合药物。审查了沉淀分析的结果,在新的和众所周知的水溶性聚合物存在下纤维状活性炭悬浮液的聚集稳定性和流变性质的研究。已经发现,通过WSCD稳定的悬浮液显示出最低的结构化程度,最高的稳定性,更窄的粒度分布以及更多的不能重力沉降的颗粒。这种理化悬浮特性与高比表面积和吸附活性相结合,使得可以获得具有更高生物利用度的药物,从而减少了治疗剂量和治疗时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号